Drug Safety and Risk Management Advisory Committee Notice of Meeting
Document ID: FDA-2012-N-0548-0086
Comments
Total: 399
< Prev Page
Page 1
... Page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
... Page 13
Page 14
Next Page >
Go To Page:
-
Randall Theodore Young - Comment
Posted : 02/06/2013 ID :FDA-2012-N-0548-0237 Agency : FDA -
Feb 01,2013 11:59 PM ET
-
Jeffrey Sinko - Comment
Posted : 02/06/2013 ID :FDA-2012-N-0548-0238 Agency : FDA -
Feb 01,2013 11:59 PM ET
-
Donn Edwin Neurman - Comment
Posted : 02/06/2013 ID :FDA-2012-N-0548-0239 Agency : FDA -
Feb 01,2013 11:59 PM ET
-
Steven Jensen - Comment
Posted : 02/06/2013 ID :FDA-2012-N-0548-0240 Agency : FDA -
Feb 01,2013 11:59 PM ET
-
Jeff Bruce Lindoo - Comment
Posted : 02/06/2013 ID :FDA-2012-N-0548-0241 Agency : FDA -
Feb 01,2013 11:59 PM ET
-
LESLIE ERNEST PONDER - Comment
Posted : 02/06/2013 ID :FDA-2012-N-0548-0242 Agency : FDA -
Feb 01,2013 11:59 PM ET
-
Brian Eugene Smith - Comment
Posted : 02/06/2013 ID :FDA-2012-N-0548-0243 Agency : FDA -
Feb 01,2013 11:59 PM ET
-
Royer Pharmacy - Comment
Posted : 02/06/2013 ID :FDA-2012-N-0548-0244 Agency : FDA -
Feb 01,2013 11:59 PM ET
-
Brent Stevan Stogdill - Comment
Posted : 02/06/2013 ID :FDA-2012-N-0548-0245 Agency : FDA -
Feb 01,2013 11:59 PM ET
-
Sardar Rafiq Ahmad - Comment
Posted : 02/06/2013 ID :FDA-2012-N-0548-0246 Agency : FDA -
Feb 01,2013 11:59 PM ET
-
Larry Thomas Palmer - Comment
Posted : 02/06/2013 ID :FDA-2012-N-0548-0247 Agency : FDA -
Feb 01,2013 11:59 PM ET
-
Flynn Wilford Warren - Comment
Posted : 02/06/2013 ID :FDA-2012-N-0548-0248 Agency : FDA -
Feb 01,2013 11:59 PM ET
-
Walter R Kraus - Comment
Posted : 02/06/2013 ID :FDA-2012-N-0548-0249 Agency : FDA -
Feb 01,2013 11:59 PM ET
-
Paul Reed - Comment
Posted : 02/06/2013 ID :FDA-2012-N-0548-0250 Agency : FDA -
Feb 01,2013 11:59 PM ET
-
joseph michael cioli - Comment
Posted : 02/06/2013 ID :FDA-2012-N-0548-0251 Agency : FDA -
Feb 01,2013 11:59 PM ET
-
Steven Pettit - Comment
Posted : 02/06/2013 ID :FDA-2012-N-0548-0252 Agency : FDA -
Feb 01,2013 11:59 PM ET
-
Helen Vu - Comment
Posted : 02/06/2013 ID :FDA-2012-N-0548-0253 Agency : FDA -
Feb 01,2013 11:59 PM ET
-
Pete Ciaramita - Comment
Posted : 02/06/2013 ID :FDA-2012-N-0548-0254 Agency : FDA -
Feb 01,2013 11:59 PM ET
-
Jack M Andersen - Comment
Posted : 02/06/2013 ID :FDA-2012-N-0548-0255 Agency : FDA -
Feb 01,2013 11:59 PM ET
-
Tim J Lehan - Comment
Posted : 02/06/2013 ID :FDA-2012-N-0548-0256 Agency : FDA -
Feb 01,2013 11:59 PM ET
-
Matt Colvin - Comment
Posted : 02/06/2013 ID :FDA-2012-N-0548-0257 Agency : FDA -
Feb 01,2013 11:59 PM ET
-
Tom Kelly - Comment
Posted : 02/06/2013 ID :FDA-2012-N-0548-0258 Agency : FDA -
Feb 01,2013 11:59 PM ET
-
Kristin Lange - Comment
Posted : 02/07/2013 ID :FDA-2012-N-0548-0259 Agency : FDA -
Feb 01,2013 11:59 PM ET
-
Joseph A Korkames - Comment
Posted : 02/07/2013 ID :FDA-2012-N-0548-0260 Agency : FDA -
Feb 01,2013 11:59 PM ET
-
Christina Whited - Comment
Posted : 02/07/2013 ID :FDA-2012-N-0548-0261 Agency : FDA -
Feb 01,2013 11:59 PM ET
-
Michael J Vande Bunte - Comment
Posted : 02/07/2013 ID :FDA-2012-N-0548-0262 Agency : FDA -
Feb 01,2013 11:59 PM ET
-
Robert Daniel Ray - Comment
Posted : 02/07/2013 ID :FDA-2012-N-0548-0263 Agency : FDA -
Feb 01,2013 11:59 PM ET
-
DEBORAH KAY COOK - Comment
Posted : 02/07/2013 ID :FDA-2012-N-0548-0264 Agency : FDA -
Feb 01,2013 11:59 PM ET
-
Jason Ray Evans - Comment
Posted : 02/07/2013 ID :FDA-2012-N-0548-0265 Agency : FDA -
Feb 01,2013 11:59 PM ET
-
Robert L Maher Sr - Comment
Posted : 02/07/2013 ID :FDA-2012-N-0548-0266 Agency : FDA -
Feb 01,2013 11:59 PM ET
< Prev Page
Page 1
... Page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
... Page 13
Page 14
Next Page >
Go To Page: